Clinical Trials Search at Vanderbilt-Ingram Cancer Center

A Prospective, Open Label, Post Marketing Surveillance Study Following Transfusion of INTERCEPT Platelet Components

Hematologic

WAPPS- Hemo (Web Accessible Population Pharmacokinetics Service - Hemophilia)
Protocol ? Phase 2: Testing and Validation

Phase III, Open-Label, Single-Dose, Multi-Center Multinational Trial Investigating a Serotype 5 Adeno-Associated Viral Vector Containing the Padua Variant of a Codon-Optimized Human Factor IX Gene (AAV5-hFIXco-Padua, AMT-061) Administered to Adult Subjects with Severe or Moderately Severe Hemophilia B

A Prospective Non-Interventional Study of Bleeding Episodes, Factor VIII Infusions, and Patient-Reported Outcomes in Individuals with Severe Hemophilia A